论文信息 - Thromboembolic complications of intravenous immunoglobulin (IVIG) in an immunocompromised patient with Chronic Lymphocytic Leukemia: a case report - 字舞流文

Thromboembolic complications of intravenous immunoglobulin (IVIG) in an immunocompromised patient with Chronic Lymphocytic Leukemia: a case report

G. Colvin | S. Dalia | C. Milani

[1] M. Eibl. History of immunoglobulin replacement. , 2008, Immunology and allergy clinics of North America.

[2] I. Marie,et al. Intravenous immunoglobulin‐associated arterial and venous thrombosis; report of a series and review of the literature , 2006, The British journal of dermatology.

[3] Y. Shoenfeld,et al. IVIg therapy in autoimmunity and related disorders: our experience with a large cohort of patients , 2005, Autoimmunity.

[4] D. Elston. Intravenous immunoglobulin: a life-saving (and potentially fatal) treatment. , 2004, Cutis.

[5] R. Benecke,et al. Therapy with Intravenous Immunoglobulins: Complications and Side-Effects , 2003, European Neurology.

[6] M. Cartwright,et al. The clinical features of 16 cases of stroke associated with administration of IVIg , 2003, Neurology.

[7] R. Hughes,et al. Intravenous immunoglobulin in neurological disease: a specialist review , 2002, Journal of neurology, neurosurgery, and psychiatry.

[8] G. Bernardi,et al. Muscle phosphofructokinase deficiency , 1997, Neurology.

[9] M. Dalakas. High‐dose intravenous immunoglobulin and serum viscosity , 1994, Neurology.